[Clinical trial of diflucortolone. Preliminary report].
Diflucortolone valerianate, a new fluorinated corticosteroid for tropical use, was applied in 52 patients suffering of diverse inflammatory dermatosis. The maximum observation time was 3 weeks. The results were, very good in 63.46%; good in 28.84%; regular in 1.92 %, and bad in 5.76%. In 73.7% of the cases good results were obtained in less than 2 weeks. The cream was cosmetically well accepted and there were no observed side effects.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003872:Dermatitis / Q000188:drug therapy*; D004060:Diflucortolone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005448:Fluocortolone / Q000031:analogs & derivatives*; D006801:Humans; D007223:Infant; D008875:Middle Aged; D009824:Ointments
D009824:Ointments; C013486:diflucortolone valerate; D005448:Fluocortolone; D004060:Diflucortolone
Ensayo clínico de la diflucortolona. Reporte preliminar.